In contrast, all T2D donors received glucose-regulating medication (two metformin alone, one metformin and glimepiride, one insulin Insulatard, and two unspecified), and two were using statins (one simvastatin, one unspecified). The gene discussed is INS; the disease is type 2 diabetes mellitus.